Clinical Trial: Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Social Anxiety Disorder
Study Type: INTERVENTIONAL
Official Title: A Phase 2a, Exploratory, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability, and Efficacy of EMP-01 in Adult Participants With Social Anxiety Disorder
Brief Summary:
This Phase 2 study (protocol number EMP-01-201) will determine the safety and tolerability of a short-term treatment with an oral dosage form of EMP-01 in adult participants with social anxiety disorder (SAD) and will assess exploratory efficacy of repeated doses of EMP-01 versus placebo.
Read more